Skip to content
Tuesday, August 4, 2026
  • Procter & Gamble to buy Thorne for $3.8 billion, CEO tells CNBC
  • Palantir stock rises 27% on soaring commercial revenue, AI sovereignty
  • Wayfair (W) earnings Q2 2026
  • Bessent says U.S. backed Japan’s yen intervention to help stabilize Asia
https://ukusanews.com/

UK & USA NEWS

Newsletter
Random News
  • Poltics
  • Sports
  • Entertainment
  • Business
  • Health
  • Tech
  • Biography
  • World
  • Procter & Gamble to buy Thorne for $3.8 billion, CEO tells CNBC
  • Palantir stock rises 27% on soaring commercial revenue, AI sovereignty
  • Wayfair (W) earnings Q2 2026
  • Bessent says U.S. backed Japan’s yen intervention to help stabilize Asia
https://ukusanews.com/

UK & USA NEWS

Newsletter
Random News
  • Poltics
  • Sports
  • Entertainment
  • Business
  • Health
  • Tech
  • Biography
  • World
Headlines
  • Procter & Gamble to buy Thorne for $3.8 billion, CEO tells CNBC

    57 minutes ago
  • Palantir stock rises 27% on soaring commercial revenue, AI sovereignty

    2 hours ago
  • Wayfair (W) earnings Q2 2026

    3 hours ago
  • Bessent says U.S. backed Japan’s yen intervention to help stabilize Asia

    4 hours ago
  • Pfizer (PFE) earnings Q2 2026

    5 hours ago
  • Merck (MRK) earnings Q2 2026

    6 hours ago
  • Takaichi’s fiscal push could lift growth — and Japan’s already-rising interest bill

    7 hours ago
  • Treasury yields are broadly flat as investors mull uncertainty around peace talks

    8 hours ago
  • Trump warns Iran talks are ‘last chance’ to end war

    9 hours ago
  • BP profit more than doubles as Trump blasts Big Oil for ‘making too much money’

    10 hours ago
  • Home
  • Biotech and Pharmaceuticals
  • Page 6

Biotech and Pharmaceuticals

  • Business

Trump administration finalizes Medicare Advantage payment rate

Sagar4 months ago02 mins

Administrator for the Centers for Medicare & Medicaid Services Mehmet Oz speaks during an event sponsored by the Action for Progress Coalition, at the National Press Club in Washington, D.C., U.S., Feb. 2, 2026. Al Drago | Reuters The Trump administration on Monday finalized a 2027 payment rate increase to privately run Medicare plans that…

Read More
  • Business

Trump prepares pharmaceutical tariffs of up to 100%

Sagar4 months ago04 mins

The Trump administration on Thursday imposed new tariffs on branded drugs from pharmaceutical companies that have not struck deals with the president to lower their U.S. drug prices – a long-awaited move that will likely only affect a small portion of drugmakers. “We need to make sure that our drug supply is protected, secure and…

Read More
  • Business

Eli Lilly reaches deal to bring AI-developed drugs to global market

Sagar4 months ago02 mins

A drone view shows the Eli Lilly logo on the company’s office in San Diego, California, Nov. 21, 2025. Mike Blake | Reuters BEIJING — U.S. pharmaceutical giant Eli Lilly has reached a $2.75 billion deal to bring drugs developed using artificial intelligence by Hong Kong-based Insilico Medicine to the global market. The agreement will give Insilico…

Read More
  • Business

Every Cure’s drug repurposing could change rare disease treatment

Sagar4 months ago010 mins

Dr. David Fajgenbaum, one of the founders of Every Cure, a nonprofit focused on drug repurposing. Courtesy of Every Cure A version of this story first appeared in the CNBC Cures newsletter. Click here to sign up. There are over 10,000 rare diseases — 95% of which don’t have a cure. It can cost billions…

Read More
  • Business

Abivax in no rush for deal, confident in June trial data: CEO

Sagar4 months ago04 mins

Abivax is planning to raise money after releasing key trial data in June, its CEO told CNBC on Tuesday, signaling to potential buyers of the firm that it is in no rush to sell. Intense takeover rumors have surrounded the French biotech company for months, impacting the volatile stock that rose nearly 1,700% in 2025….

Read More
  • Business

Menstrual products prices skyrocketing from inflation, tariffs

Sagar5 months ago07 mins

Always products are displayed on a shelf in a supermarket in Sarajevo, Bosnia and Herzegovina October 29, 2024.  Dado Ruvic | Reuters Rising inflation and ever-changing tariff policies have led to higher prices across store shelves over the past few years, squeezing consumers’ budgets. An often overlooked example: menstrual products. The average price of menstrual…

Read More
  • Business

How CNBC Cures is bringing rare disease stories to a national audience

Sagar5 months ago04 mins

Last summer, my sister Becky approached me with an idea. She wanted my help building a platform at CNBC to spotlight the 30 million Americans living with a rare disease. Becky hoped that doing so would help give a voice to the millions of people that are often overlooked by the medical community … who…

Read More
  • Business

Icotyde psoriasis pill from J&J to rival Tremfya Skyrizi IL-23 shots

Sagar5 months ago02 mins

Signage outside Johnson & Johnson offices in Irvine, California, US, on Friday, Oct. 10, 2025. Kyle Grillot | Bloomberg | Getty Images Johnson & Johnson on Wednesday said the U.S. Food and Drug Administration approved its once-daily psoriasis pill, the first oral option to rival best-selling shots. The FDA approved the pill, Icotyde, to treat…

Read More
  • Business

Novo Nordisk ends legal proceedings against Hims & Hers

Sagar5 months ago04 mins

Novo Nordisk has dropped its legal case against telehealth provider Hims & Hers over patent infringement, after the two companies agreed Hims would sell Novo’s branded medicines through its platform.  “We have decided to drop the current court proceedings and, of course, we reserve to bring that back if need be, but I don’t foresee…

Read More
  • Business

FDA reversals on UniQure, Moderna approvals worry investors

Sagar5 months ago06 mins

Investors are concerned about the fates of multiple experimental drugs for hard-to-treat diseases following a string of recent rejections from the U.S. Food and Drug Administration.  The FDA in the past year has denied or discouraged the applications of at least eight drugs, according to RTW Investments, including a gene therapy for Huntington’s disease from…

Read More
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 16

Recent Posts

  • Procter & Gamble to buy Thorne for $3.8 billion, CEO tells CNBC
  • Palantir stock rises 27% on soaring commercial revenue, AI sovereignty
  • Wayfair (W) earnings Q2 2026
  • Bessent says U.S. backed Japan’s yen intervention to help stabilize Asia
  • Pfizer (PFE) earnings Q2 2026

Recent Comments

  1. Visit This Link on Trump Applauds Massive Russia-Ukraine Prisoner Swap, Hints at ‘Something Big’ in Peace Talks
  2. Buy SEO Backlinks on Trump Applauds Massive Russia-Ukraine Prisoner Swap, Hints at ‘Something Big’ in Peace Talks
  3. Birkin Hotsell Yellow Bag on Trump Applauds Massive Russia-Ukraine Prisoner Swap, Hints at ‘Something Big’ in Peace Talks
  4. scar removal treatment on LA Riots: Can Trump Send in the National Guard? Here’s What the Insurrection Act Says
  5. affordable insurance coverage on Russia-Ukraine War: Is a Ceasefire Near? Trump Plans to Call Putin and Zelensky

Archives

  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025

Categories

  • Biography
  • Business
  • Entertainment
  • Health
  • Poltics
  • Sports
  • Tech
  • World
Copyright [2026] | Powered by ukusanews.com Powered By BlazeThemes.
  • About Us
  • Contect Us
  • Fact checking Policy
  • DNAPA Code of Ethics
  • Correction Policy
  • Privacy Policy